1/75
Comprehensive practice flashcards covering acid-base balance, arterial blood gas interpretation, fluid compartments, electrolyte imbalances, renal physiology, and common urinary elimination disorders.
Normal Blood pH
The physiological range of arterial blood pH, maintained between 7.35 and 7.45. Acidosis is characterized by a pH<7.35 (↑H+), while alkalosis is defined as a pH>7.45 (↓H+).
Bicarbonate (HCO3−) Buffer System
The primary extracellular chemical buffer that acts immediately to minimize blood pH fluctuations by binding excess hydrogen ions (H+) to prevent acidosis or releasing them to counter alkalosis.
Respiratory Regulation of Acid-Base Balance
The physiological mechanism where the lungs regulate blood CO2 (an acid) within minutes. Acidosis triggers increased respirations to blow off CO2 (↑pH), whereas alkalosis triggers decreased respirations to retain CO2 (↓pH).
Renal Regulation of Acid-Base Balance
The sustained regulatory mechanism provided by the kidneys over hours to days. In acidosis, the kidneys excrete H+ and retain HCO3−; in alkalosis, they excrete HCO3−.
Arterial Blood Gas (ABG) Reference Ranges
Standard clinical laboratory values for evaluating gas exchange and acid-base status: pH=7.35–7.45, PaCO2=35–45mmHg (respiratory acid), HCO3−=22–26mEq/L (metabolic base), and PaO2=80–100mmHg (oxygenation).
ROME Method
A mnemonic method for ABG interpretation meaning 'Respiratory Opposite, Metabolic Equal'. In respiratory disorders, pH and PaCO2 move in opposite directions; in metabolic disorders, pH and HCO3− move in the same direction.
Uncompensated Acid-Base Disorder
An acid-base imbalance in which the pH is outside normal limits (<7.35 or >7.45) and the non-causative parameter (PaCO2 or HCO3−) remains within its normal reference range.
Partially Compensated Acid-Base Disorder
An acid-base state in which all three ABG parameters (pH, PaCO2, and HCO3−) are abnormal, demonstrating that the opposing system is actively working to correct the pH, but normal pH is not yet achieved.
Fully Compensated Acid-Base Disorder
An acid-base state where the pH has returned to the normal range (7.35–7.45), but both PaCO2 and HCO3− remain abnormal. A pH<7.40 points toward a compensated acidosis, whereas a pH>7.41 points toward a compensated alkalosis.
Metabolic Acidosis
An acid-base disorder marked by pH<7.35 and HCO3−<22mEq/L. Common etiologies include diabetic ketoacidosis (excess ketones), shock/sepsis (lactic acid accumulation), severe diarrhea (loss of bicarbonate), and kidney failure (decreased acid excretion).
Kussmaul Respirations
Deep, rapid breathing observed in metabolic acidosis (notably DKA) that serves as a compensatory mechanism by the lungs to exhale large quantities of CO2 to elevate blood pH.
Sodium Bicarbonate (IV)
An intravenous alkalinizing agent that increases HCO3− to raise blood pH; reserved for selected severe metabolic acidosis or hyperkalemia with significant acidosis. Potential adverse effects include metabolic alkalosis, hypernatremia, fluid overload, and tissue necrosis from IV extravasation.
Metabolic Alkalosis
An acid-base disorder defined by pH>7.45 and HCO3−>26mEq/L, caused by loss of gastric acid (prolonged vomiting, NG suctioning), loop or thiazide diuretic therapy, or excess bicarbonate/antacid intake. Compensatory response is hypoventilation to retain CO2.
Respiratory Acidosis
An acid-base disorder characterized by pH<7.35 and PaCO2>45mmHg due to hypoventilation and CO2 retention. Etiologies include COPD, opioid/sedative overdose, airway obstruction, and neuromuscular weakness (ALS, Guillain-Barré syndrome).
CO2 Narcosis
A severe clinical manifestation of elevated arterial CO2 retention characterized by progressive drowsiness, confusion, headache, and decreased level of consciousness (LOC) that can deteriorate into respiratory failure and coma.
Respiratory Alkalosis
An acid-base disorder marked by pH>7.45 and PaCO2<35mmHg caused by hyperventilation and excessive CO2 loss. Common causes include anxiety/panic attacks, pulmonary embolism (PE), pneumonia, hypoxemia, and excessive mechanical ventilation settings.
Major Electrolyte Normal Reference Ranges
Standard serum concentrations: Sodium (Na+) 135–145mEq/L, Potassium (K+) 3.5–5mEq/L, Calcium (Ca2+) 8.5–10.5mg/dL, Magnesium (Mg2+) 1.5–2.5mg/dL, and Phosphorus 2.5–4.5mg/dL.
Hormonal Regulators of Electrolytes
Endocrine mechanisms governing electrolyte levels: Aldosterone retains sodium and excretes potassium; ADH conserves free water (diluting sodium); PTH elevates serum calcium and promotes phosphate excretion; and Vitamin D increases intestinal calcium and phosphate absorption.
Hyponatremia
A serum sodium level <135mEq/L. Decreased extracellular osmolality causes water to shift into cells, resulting in brain cell swelling and cerebral edema, presenting with nausea, headache, weakness, confusion, seizures, and coma.
Hypertonic Saline (3% NaCl)
A hypertonic IV crystalloid that increases serum sodium and extracellular osmolality, pulling water out of swollen cells (such as brain cells) to manage severe symptomatic hyponatremia (e.g., seizures). Overly rapid administration risks osmotic demyelination syndrome (ODS).
Osmotic Demyelination Syndrome (ODS)
A serious, potentially permanent neurological disorder resulting from overly rapid correction of chronic hyponatremia, characterized by destruction of the myelin sheath in the brainstem.
Hypernatremia
A serum sodium level >145mEq/L. Increased extracellular osmolality draws water out of cells into the vascular space, leading to intracellular dehydration and brain cell shrinkage. Primary clinical signs include thirst, restlessness, confusion, and seizures.
Diabetes Insipidus (DI) vs. SIADH
DI involves deficient ADH activity leading to free water loss, polyuria (large, dilute urine), hypernatremia, and high serum osmolality (managed with desmopressin). SIADH involves excess ADH causing water retention, oliguria (scant, concentrated urine), dilutional hyponatremia, and low serum osmolality (managed with fluid restriction).
Hypokalemia
A serum potassium level <3.5mEq/L. Caused by vomiting, diarrhea, loop/thiazide diuretics, or intracellular shifts (insulin, albuterol). Manifestations include muscle weakness, cramps, paralytic ileus, paresthesias, and life-threatening cardiac dysrhythmias.
Intravenous Potassium Chloride (KCl) Safety Rules
Critical safety mandates for IV KCl administration: NEVER administer via IV push, bolus, or undiluted due to fatal cardiac arrest risk; always dilute in IV fluids and infuse via an electronic infusion pump at the prescribed rate with continuous cardiac monitoring.
Hyperkalemia
A serum potassium level >5mEq/L, commonly caused by kidney dysfunction (AKI, CKD), ACE inhibitors, ARBs, spironolactone, or excessive salt substitutes (e.g., Nu-Salt). Alters myocardial conduction, presenting with weakness, paresthesias, flaccid paralysis, and life-threatening cardiac arrest.
Hyperkalemia Three-Step Emergency Management
Step 1: Protect the heart by administering IV calcium gluconate to stabilize cardiac membranes. Step 2: Shift potassium into cells with IV regular insulin plus dextrose or inhaled albuterol. Step 3: Remove potassium from the body with loop diuretics, sodium polystyrene sulfonate (Kayexalate), or hemodialysis.
Sodium Polystyrene Sulfonate (Kayexalate)
A cation-exchange resin that binds potassium in the gastrointestinal tract to be eliminated in the stool. Adverse effects include GI disturbances and rare intestinal necrosis; it is contraindicated in patients with bowel obstruction.
Hypocalcemia
A serum calcium level <8.5mg/dL. Causes increased neuromuscular excitability leading to tingling, muscle cramps, tetany, seizures, prolonged QT interval, and life-threatening laryngospasm with stridor. Common causes include hypoparathyroidism (after neck/thyroid surgery), vitamin D deficiency, and CKD.

Trousseau Sign and Chvostek Sign
Classic physical indicators of neuromuscular irritability associated with hypocalcemia. Chvostek sign is facial muscle twitching produced by tapping the facial nerve; Trousseau sign is carpal spasm elicited by inflating a blood pressure cuff above systolic pressure for several minutes.
Calcium Gluconate
An intravenous mineral replacement used to treat severe symptomatic hypocalcemia, counteract hypermagnesemia, and immediately stabilize myocardial excitable membranes in severe hyperkalemia. It is a vesicant that can cause tissue necrosis if extravasated.
Hypercalcemia
A serum calcium level >10.5mg/dL, most commonly caused by hyperparathyroidism, malignancy, and prolonged immobilization. Decreases neuromuscular excitability, manifesting as muscle weakness, constipation, polyuria, polydipsia, renal calculi, and cardiac dysrhythmias.
Hypomagnesemia
A serum magnesium level <1.5mg/dL. Characterized by increased neuromuscular excitability, resulting in tremors, hyperreflexia (increased DTRs), tetany, seizures, and dysrhythmias. Commonly caused by chronic alcohol use disorder, diarrhea, and loop diuretics.
Magnesium Sulfate (IV)
An intravenous electrolyte replacement used for severe hypomagnesemia, eclamptic seizure prophylaxis, and specific cardiac dysrhythmias. Toxicity leads to depressed/absent DTRs, respiratory depression, hypotension, and cardiac arrest; the specific antidote is IV calcium gluconate.
Hypermagnesemia
A serum magnesium level >2.5mg/dL, typically occurring in renal dysfunction coupled with magnesium-containing antacids or laxatives (e.g., Milk of Magnesia). Causes decreased neuromuscular excitability, loss of DTRs, muscle flaccidity, bradycardia, hypotension, and respiratory depression.
Hypophosphatemia
A serum phosphate level <2.5mg/dL. Results in impaired cellular ATP synthesis, leading to muscle weakness and potential respiratory muscle failure (especially when phosphate <1mg/dL). Classic causes include malnutrition and refeeding syndrome.
Refeeding Syndrome
A potentially fatal metabolic complication occurring upon rapid nutritional reintroduction in severely malnourished individuals; sudden insulin secretion drives phosphate, potassium, and magnesium into cells, triggering severe acute hypophosphatemia.
Hyperphosphatemia
A serum phosphate level >4.5mg/dL, most frequently seen in chronic kidney disease (CKD). High phosphate binds serum calcium, causing secondary hypocalcemia (tetany, cramps) and chronic calcium-phosphate crystal deposition in soft tissues and blood vessels.
Phosphate Binders (Sevelamer vs. Calcium Acetate)
Gastrointestinal agents taken with meals to bind dietary phosphate and excrete it in feces. Sevelamer (Renvela) is calcium-free and indicated when calcium levels are elevated; Calcium Acetate (PhosLo) contains calcium and is chosen when calcium is low or normal.
Erythropoietin (EPO)
A glycoprotein hormone synthesized and released by the kidneys in response to tissue hypoxia that stimulates red blood cell (erythrocyte) production in bone marrow; production declines significantly in chronic kidney disease, causing anemia.
Nephron
The structural and functional unit of the kidney, numbering roughly 1 million per kidney. Consists of a glomerulus and tubular network responsible for filtering blood, selective reabsorption, secretion, and urine production.
Pathway of Urine Flow
The sequential anatomical route of urine: Nephron (filters blood) → Collecting ducts → Renal calyces → Renal pelvis → Ureters → Urinary bladder → Urethra (exterior).
Vesicoureteral Reflux (VUR)
An abnormal retrograde backflow of urine from the urinary bladder upward into the ureters and kidneys, predisposing patients to recurrent ascending urinary tract infections, pyelonephritis, and progressive renal parenchymal scarring.
Detrusor Muscle
The smooth muscle wall of the urinary bladder that remains relaxed during bladder filling and contracts during micturition (urination) to expel urine into the urethra.
Glomerular Filtration Rate (GFR)
The volume of plasma filtered through the glomerular capillaries per minute, representing the best overall clinical indicator of renal function: healthy GFR ≥90, mildly decreased GFR 60–89, and kidney failure <15.
Serum Creatinine
A waste product of muscle metabolism excreted exclusively by the kidneys (normal range 0.7–1.4mg/dL). It exhibits an inverse relationship with GFR and serves as a highly specific diagnostic indicator of kidney function.
Blood Urea Nitrogen (BUN)
A waste product of hepatic protein metabolism eliminated by renal excretion (normal range 7–20mg/dL). Less specific for renal function than creatinine because elevations also result from dehydration, gastrointestinal bleeding, or high protein intake.
Polycystic Kidney Disease (PKD)
A genetic disorder characterized by the development of numerous fluid-filled bilateral renal cysts that progressively enlarge, compress nephrons, and destroy renal parenchyma. Autosomal dominant PKD presents in adulthood (most common); autosomal recessive PKD presents in infancy or childhood.
Tolvaptan
A selective vasopressin V2-receptor antagonist used to slow kidney function decline and inhibit cyst growth in select patients diagnosed with autosomal dominant polycystic kidney disease (ADPKD).
Hemodialysis (HD) vs. Peritoneal Dialysis (PD)
Extracorporeal dialysis (HD) circulates blood through a synthetic dialyzer membrane machine to clear toxins and excess fluid before returning it to circulation; peritoneal dialysis (PD) uses the vascular peritoneal membrane as a natural filter by infusing dialysate into the abdominal cavity and draining it.
Nephrotic Syndrome
A renal condition resulting from damaged glomerular basement membranes with increased permeability to proteins, marked by heavy proteinuria (>3.5g/day, foamy urine), hypoalbuminemia, reduced plasma oncotic pressure, pronounced dependent/periorbital edema, and hyperlipidemia.
Nephritic Syndrome
A syndrome caused by acute glomerular inflammation that impairs filtration, characterized by hematuria (often cola-colored urine with red blood cell casts), mild-to-moderate edema, hypertension, oliguria, and a decreased GFR.
Acute Pyelonephritis
An acute bacterial infection and inflammation of the renal pelvis and parenchyma, most commonly caused by ascending Escherichia coli (E. coli). Manifests with fever, chills, nausea, flank pain, and costovertebral angle (CVA) tenderness.

Costovertebral Angle (CVA) Tenderness
A diagnostic physical finding in which dull percussion over the costovertebral angle (formed by the 12th rib and spine over the kidneys) elicits sharp pain, indicating acute renal inflammation such as pyelonephritis.
Renal Calculi (Nephrolithiasis)
Hard crystalline mineral deposits formed in the kidneys (calcium oxalate being the most common). Classic presentation is acute, severe, spasmodic flank pain that radiates to the groin (renal colic) accompanied by hematuria; obstructing stones with infection represent a urological medical emergency.
Extracorporeal Shock Wave Lithotripsy (ESWL)
A noninvasive surgical procedure utilizing acoustic shock waves directed through the body to fragment renal calculi into sand-like particles small enough to pass spontaneously through the urinary tract.
Benign Prostatic Hyperplasia (BPH)
A noncancerous enlargement of the prostate gland in men over 50 caused by 5-alpha-reductase converting testosterone into dihydrotestosterone (DHT). Compresses the urethra, leading to hesitancy, weak stream, intermittency, incomplete bladder emptying, and overflow dribbling.
Tamsulosin
An alpha-1 adrenergic antagonist that relaxes smooth muscle in the prostate and bladder neck to improve urinary flow in BPH without altering the physical size of the prostate. Notable risks include orthostatic hypotension and intraoperative floppy iris syndrome during cataract surgery.
Finasteride
A 5-alpha-reductase inhibitor that blocks the conversion of testosterone to DHT, physically shrinking enlarged prostate tissue over 3–6 months in BPH. It lowers baseline PSA by approximately 50% and is teratogenic to male fetuses (pregnant women must not handle crushed/broken tablets).
Stress Incontinence
Involuntary loss of urine associated with sudden increases in intra-abdominal pressure (e.g., sneezing, coughing, laughing, or exercising) resulting from pelvic floor muscle weakness or urethral sphincter hypermobility. Managed with Kegel exercises or mid-urethral sling surgery.
Overflow Incontinence
Involuntary dribbling or leakage of urine from an overdistended bladder due to bladder outlet obstruction (BPH, urethral stricture) or detrusor hypoactivity/atonicity (diabetic neuropathy, spinal injury). Managed with catheterization or alleviating obstruction.
Functional Incontinence
Involuntary loss of urine occurring in patients with normal lower urinary tract physiology who are unable to reach the toilet or remove clothing in time due to severe cognitive impairment (dementia) or physical mobility limitations.
Urge Incontinence
A sudden, compelling urge to void followed immediately by involuntary urine leakage, caused by uninhibited detrusor muscle overactivity during bladder filling (overactive bladder). Managed with bladder training, antimuscarinics, or beta-3 agonists.
Oxybutynin
An antimuscarinic (anticholinergic) medication for urge incontinence and overactive bladder that blocks muscarinic receptors to inhibit detrusor contractions and increase bladder storage capacity. Classical adverse effects include dry mouth, blurred vision, urinary retention, constipation, and delirium in older adults.
Mirabegron
A beta-3 adrenergic receptor agonist that stimulates detrusor relaxation during bladder filling to increase functional bladder capacity in urge incontinence/OAB. It is not recommended in patients with severe, uncontrolled hypertension.
Bethanechol
A parasympathomimetic (cholinergic agonist) that stimulates muscarinic receptors to promote detrusor muscle contraction and bladder emptying in nonobstructive urinary retention. Contraindicated in mechanical obstruction and asthma; atropine is the antidote.
Chronic Kidney Disease (CKD)
Persistent structural or functional kidney damage present for ≥3 months. Diabetes mellitus and hypertension are the primary etiologies. Progressive nephron loss leads to fluid retention, hyperkalemia, anemia (reduced EPO), uremia, and metabolic acidosis.
Total Body Water (TBW) and Fluid Compartments
Total body water accounts for 50–60% of adult body weight (lower in older adults). It is divided into intracellular fluid (ICF, fluid inside cells) and extracellular fluid (ECF, subdivided into intravascular plasma and interstitial tissue fluid).
Diffusion vs. Osmosis
Diffusion is the passive movement of solutes from an area of higher concentration to lower concentration; Osmosis is the movement of water across a semipermeable membrane from an area of lower solute concentration toward an area of higher solute concentration.
Capillary Hydrostatic vs. Oncotic Pressure
Hydrostatic pressure is the mechanical filtration force that pushes fluid out of capillaries into interstitial tissues (e.g., elevated in heart failure). Oncotic (colloid osmotic) pressure is the pulling force created by plasma proteins (especially albumin) that draws fluid into capillaries.

Tonicity
The osmotic effect of an extracellular fluid on cell volume: isotonic solutions produce no net fluid shift (cells retain normal size); hypotonic solutions drive water into cells, causing swelling and lysis; hypertonic solutions draw water out of cells, causing cellular shriveling.
Atrial Natriuretic Peptide (ANP)
A cardiac hormone released by atrial myocytes in response to increased intravascular stretch and volume; it promotes renal sodium and water excretion, thereby reducing circulating blood volume and systemic blood pressure.
Fluid Volume Depletion (Hypovolemia)
An isotonic loss of water and sodium from the extracellular space caused by vomiting, diarrhea, burns, or hemorrhage. Manifests as tachycardia, vasoconstriction, hypotension, orthostasis, dry mucosa, oliguria, and elevated BUN; treated with isotonic crystalloids (0.9% NS or LR).
5% Dextrose in Water (D5W)
An intravenous fluid that is isotonic inside the infusion bag, but becomes physiologically hypotonic in the body once dextrose is metabolized, functioning as free water to treat hypernatremia. It is contraindicated for rapid fluid resuscitation in shock.
Fluid Volume Excess (Hypervolemia)
An isotonic expansion of extracellular fluid caused by sodium and water retention (heart failure, renal dysfunction, liver cirrhosis). Manifests as peripheral edema, jugular vein distention (JVD), hypertension, bounding pulses, dyspnea, and pulmonary crackles; managed with fluid/sodium restriction and diuretics.
Four Pathophysiological Mechanisms of Edema
The biological causes of abnormal interstitial fluid accumulation: 1) Increased capillary hydrostatic pressure (heart failure); 2) Decreased plasma oncotic pressure (hypoalbuminemia, nephrotic syndrome); 3) Increased capillary permeability (burns, sepsis, inflammation); and 4) Impaired lymphatic obstruction/drainage.